NEUEHEALTH INC (NEUE) Stock Fundamental Analysis
NYSE:NEUE - New York Stock Exchange, Inc. - US10920V4041 - Common Stock - Currency: USD
Taking everything into account, NEUE scores 2 out of 10 in our fundamental rating. NEUE was compared to 103 industry peers in the Health Care Providers & Services industry. NEUE may be in some trouble as it scores bad on both profitability and health. NEUE is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
NEUE had negative earnings in the past year.
In the past year NEUE has reported a negative cash flow from operations.
In the past 5 years NEUE always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: NEUE reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -20.35%, NEUE is not doing good in the industry: 84.47% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.35% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-54.73%
ROA(5y)-42.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for NEUE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
NEUE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NEUE has more shares outstanding
NEUE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NEUE has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -5.67, we must say that NEUE is in the distress zone and has some risk of bankruptcy.
NEUE has a Altman-Z score of -5.67. This is amonst the worse of the industry: NEUE underperforms 86.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.67 |
ROIC/WACCN/A
WACC6%
2.3 Liquidity
NEUE has a Current Ratio of 3.89. This indicates that NEUE is financially healthy and has no problem in meeting its short term obligations.
NEUE's Current ratio of 3.89 is amongst the best of the industry. NEUE outperforms 87.38% of its industry peers.
A Quick Ratio of 3.89 indicates that NEUE has no problem at all paying its short term obligations.
The Quick ratio of NEUE (3.89) is better than 89.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.89 | ||
| Quick Ratio | 3.89 |
3. Growth
3.1 Past
The earnings per share for NEUE have decreased strongly by -87.23% in the last year.
The Revenue for NEUE has decreased by -19.28% in the past year. This is quite bad
NEUE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.26% yearly.
EPS 1Y (TTM)-87.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.89%
Revenue 1Y (TTM)-19.28%
Revenue growth 3Y-14.76%
Revenue growth 5Y27.26%
Sales Q2Q%-7.48%
3.2 Future
Based on estimates for the next years, NEUE will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.62% on average per year.
Based on estimates for the next years, NEUE will show a quite strong growth in Revenue. The Revenue will grow by 16.81% on average per year.
EPS Next Y14%
EPS Next 2Y11.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.84%
Revenue Next 2Y16.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
NEUE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NEUE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.62%
EPS Next 3YN/A
5. Dividend
5.1 Amount
NEUE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:NEUE (8/11/2025, 6:40:01 PM)
6.68
-0.04 (-0.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners51.74%
Inst Owner ChangeN/A
Ins Owners12.11%
Ins Owner Change49.96%
Market Cap59.65M
Analysts42.86
Price Target7.14 (6.89%)
Short Float %0.11%
Short Ratio1.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)92.87%
Min EPS beat(2)74.72%
Max EPS beat(2)111.02%
EPS beat(4)2
Avg EPS beat(4)10.79%
Min EPS beat(4)-118.63%
Max EPS beat(4)111.02%
EPS beat(8)4
Avg EPS beat(8)64.09%
EPS beat(12)5
Avg EPS beat(12)32.51%
EPS beat(16)5
Avg EPS beat(16)-7.43%
Revenue beat(2)0
Avg Revenue beat(2)-21.26%
Min Revenue beat(2)-33.05%
Max Revenue beat(2)-9.47%
Revenue beat(4)0
Avg Revenue beat(4)-14.39%
Min Revenue beat(4)-33.05%
Max Revenue beat(4)-2.77%
Revenue beat(8)1
Avg Revenue beat(8)-8.65%
Revenue beat(12)2
Avg Revenue beat(12)-20.61%
Revenue beat(16)3
Avg Revenue beat(16)-35.97%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.07 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-6.16
EYN/A
EPS(NY)-14.9
Fwd EYN/A
FCF(TTM)-11.04
FCFYN/A
OCF(TTM)-10.67
OCFYN/A
SpS101.61
BVpS-49.36
TBVpS-57.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.35% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-54.73%
ROA(5y)-42.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 22.53% | ||
| Cap/Sales | 0.36% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.89 | ||
| Quick Ratio | 3.89 | ||
| Altman-Z | -5.67 |
F-Score4
WACC6%
ROIC/WACCN/A
Cap/Depr(3y)27.02%
Cap/Depr(5y)49%
Cap/Sales(3y)0.54%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.89%
EPS Next Y14%
EPS Next 2Y11.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.28%
Revenue growth 3Y-14.76%
Revenue growth 5Y27.26%
Sales Q2Q%-7.48%
Revenue Next Year28.84%
Revenue Next 2Y16.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year152.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y88.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y88.99%
OCF growth 3YN/A
OCF growth 5YN/A